Literature DB >> 19566903

HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis.

J Pietiläinen1, J O Virtanen, L Uotila, O Salonen, M Koskiniemi, M Färkkilä.   

Abstract

BACKGROUND AND
PURPOSE: To elucidate the role of human herpesvirus-6 (HHV-6) in the development of multiple sclerosis (MS). PATIENTS AND METHODS: Nine patients with MS and with acute or chronic HHV-6 infection were evaluated.
RESULTS: Intrathecal antibody production to HHV-6 and oligoclonal IgG bands in the cerebrospinal fluid (CSF) was observed in two patients with a clinically definite MS and chronic HHV-6 infection (based on the presence of HHV-6 specific antibodies in the CSF). A temporal association between the symptoms of clinically possible MS and acute primary HHV-6A infection (based on avidity of HHV-6 specific antibodies) was observed in two patients.
CONCLUSIONS: Human herpesvirus-6 infection may be an associated agent in some MS cases. Viral studies are needed to identify a possible viral etiology and give specific therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566903     DOI: 10.1111/j.1468-1331.2009.02718.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

2.  Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.

Authors:  Nourollah Ramroodi; Nima Sanadgol; Zohre Ganjali; Abbas Ali Niazi; Vida Sarabandi; Ali Moghtaderi
Journal:  J Pathog       Date:  2013-01-22

Review 3.  Human herpesvirus 6 infection as a trigger of multiple sclerosis: an update of recent literature.

Authors:  K I Voumvourakis; P C Fragkou; D K Kitsos; K Foska; M Chondrogianni; S Tsiodras
Journal:  BMC Neurol       Date:  2022-02-15       Impact factor: 2.474

Review 4.  Gut microbiome and the risk factors in central nervous system autoimmunity.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  FEBS Lett       Date:  2014-10-05       Impact factor: 4.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.